Skip to content

Clinical trials

Terminated Central Nervous System Diseases trials in France

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Central Nervous System Diseases Status: Terminated Country / region: France Clear all

9 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20141
20151
20161
20172
20182
20211
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated9

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca3
Fondation Ophtalmologique Adolphe de Rothschild1
GlaxoSmithKline1
Hoffmann-La Roche1
Remedy Pharmaceuticals, Inc.1
Shire1
University Hospital, Montpellier1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Central Nervous System Diseases9
Brain Diseases8
Nervous System Diseases7
Alzheimer Disease5
Dementia5
Mental Disorders5
Tauopathies4
Neurocognitive Disorders3
Neurodegenerative Diseases3
Brain Diseases, Metabolic, Inborn1

Trials

Showing 1 to 9 of 9. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.